Does body mass index have an effect on the prevalence of various symptoms of polycystic ovary syndrome and their associated risk factors?
DOI:
https://doi.org/10.2478/anre-2021-0013Keywords:
Body mass index, hirsutism, hyperandrogenism, menstrual disturbance, polycystic ovary syndromeAbstract
The present cross-sectional study is an attempt to understand the effect of body mass index (BMI) on the prevalence of various symptoms of polycystic ovary syndrome (PCOS) and to evaluate its associated risk factors.
A total of 250 PCOS women diagnosed by Rotterdam Criteria (2003), age ranging from 18–45 years, attending OPD of Gynaecology and Obstetrics of PGIMER, Chandigarh, India were enrolled in the study. All the participants were divided in three groups according to their body mass index (BMI). The polycystic ovaries (83.2%) were the most frequently occurring symptoms of PCOS followed by hirsutism (74.4%), oligomenorrhea (60%), seborrhea (45.2%) and acne (40%). Category wise frequency distribution showed higher prevalence of symptoms among women in overweight/obese category, which were further supported by correspondence analysis. Results of multivariate analysis revealed that marital status, type of diet, socio-economic status and physical activity level were potential risk factors contributing to severe manifestations of PCOS symptoms.
Obesity denoted as an important risk factor can exaggerate many symptoms of PCOS and also be a causative factor for menstrual disturbance.
Downloads
References
Abid Keen M, Hassan SI, Gousia S. 2017. Cutaneous manifestations of polycystic ovary syndrome: A cross-sectional clinical study. Indian Dermatol Online J 8(2):104–10. doi: 10.4103/2229-5178.202275
Agarwal OP, Bhasin SK, Sharma AK, Chabra P, Agarwal K, Rajoura OP. 2005. A new instrument (scale) for developing socio-economic status of a family. Preliminary Study. Indian J Community Med 30:111–4.
Ahmadi A, Akbarzadeh M, Mohammadi F, Akbari M, Jafari B. 2017. Anthropometric characteristics and dietary pattern of women with polycystic ovary syndrome. Indian J of Endo and Metabol :17(4):672–6. doi: 10.4103/2230-8210.113759
Akhyany M, Daneshpajouh M, Barzegari M, Ghandi N, Ghiasi M, Chenari Z, et al. 2006. The prevalence of hirsutism in female students of Tehran University School of Medicine. J Dermatol 9:242–9.
Ali AT, Guidozzi F. 2020. Midlife women health consequences associated with polycystic ovary syndrome. Climactric 23(2):116–22. doi: 10.1080/13697137.2019.1679111
Ali M, Cleland J. 1999. Determinants of contraceptive discontinuation in six developing countries. J Biosoc Sci 31(3):343–60.
Andy H, Brennan K, Azziz R. 2010. Prevalence of hyperandrogenemia in the polycystic ovary syndrome diagnosed by the National Institutes of Health 1990 criteria. Fertil Steril 93(6):1938–41. doi: 10.1016/j.fertnstert.2008.12.138
Anjana RM, Sudha V, Lakshmipriya N, Subhashini S, Pradeepa R, Geetha L. et al. 2015. Reliability and validity of a new physical activity questionnaire for India. Int J Behav Nutr Phys Act 18:12–40. doi: 10.1186/s12966-015-0196-2
Azziz R, Carmina E, Chen Z, Dunaif A, Laven JS, Leg RS. et al. 2016. Polycystic ovary syndrome. Nat Rev Dis Primers 11(2):16057. doi: 10.1038/nrdp.2016.57
Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W. et al. 2009. The androgen excess and PCOS society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril 91:456–88. doi: 10.1016/j.fertnstert.2008.06.035
Sam S, Dunaif A. 2003. Polycystic ovary syndrome: Syndrome XX?. Trends in Endocrinol Metab 14(8):365–70. doi:10.1016/j.tem.2003.08.002
Balen AH, Conway GS, Kaltsas G, Techatrasak K, Manning PJ, West C. et al. 1995.Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients. Hum Reprod 10(8):2107–11.
Balen AH, Laven JS, Tan SL, Dewailly D. 2003.Ultrasound assessment of the polycystic ovary: international consensus definitions. Hum Reprod Update 6:505–14. doi:10.1093/humupd/dmg044
Bernasconi D, Del Monte P, Meozzi M, Randazzo M, Marugo A, Badaracco B. et al. 1996.The impact of obesity on hormonal parameters in hirsute and nonhirsute women. Metabolism 45(1):72–5. doi:10.1016/s0026-0495(96)90202-4
Bharathi RV, Swetha S, Neerajaa J, Madhavica V, Janani DM, Rekha SN, et al. 2017. An epidemiological survey: Effect of predisposing factors for PCOS in Indian urban and rural population. Middle East Fertil Soc 22(4):313–6. doi:10.1016/j.mefs.2017.05.007
Carmina E, Legro RS, Stamets K, Lowell J, Lobo RA. 2003. Difference in body weight between American and Italian women with polycystic ovary syndrome: influence of the diet. Human Reproduction 18(11):2289–93.
Charan J, Biswas T. 2013. How to calculate sample size for different study designs in medical research?. Indian J Psychol Med 35(2):121–6. doi:10.4103/0253-7176.116232
Diamanti-Kandarakis E, Kandarakis H, Legro RS. 2006. The role of genes and environment in the etiology of PCOS. Endocrine 1:19–26. doi:10.1385/ENDO:30:1:19
Diamanti-Kandarakis E, Papavassiliou AG, Kandarakis SA, Chrousos GP ( 2007. Pathophysiology and types of dyslipidemia in PCOS. Trends Endocrinol Metab 18(7):280–5. doi: 10.1016/j.tem.2007.07.004
Di-Fede G, Mansueto P, Longo R, Rini GB, Carmina E. 2008. Influence of sociocultural factors on the ovulatory status of polycystic ovary syndrome. Fertil Ster il 91(5):1853–6. doi: 10.1016/j.fertnstert.2008.02.161
Esmaeilzadeh S, Andarieh MG, Ghadimi R, Delavar MA. 2015. Body Mass Index and Gonadotropin Hormones (LH & FSH) Associate With Clinical Symptoms Among Women With Polycystic Ovary Syndrome. Glob J Health Sci.7(2):101–6. oi: 10.5539/gjhs.v7n2p101
Ekwutosi MO, Hooper WC, Atrash HK, Yusuf HR, Boulet SL. 2012. Prevalence of polycystic ovary syndrome among privately insured, United States, 2003–2008. Am J Obstet Gynecol 207(4):299.e1-299.e7. doi: 10.1016/j.ajog.2012.07.023
Franks S. 1989. Polycystic ovary syndrome: a changing perspective. Clin Endo 31:87–120. doi.org/10.1111/j.1365-2265.1989.tb00457.x
Franks S, Kiddy D, Sharp P, Singh A, Reed M, Seppälä M. et al. 1991. Obesity and polycystic ovary syndrome. Ann N Y Acad Sci 626:201–6. doi: 10.1111/j.1749-6632.1991.tb37915.x
Frisch RE. 1987. Body fat, menarche, fitness and fertility. Hum Reprod 2(6):521–33.
Gambineri A, Pelusi C, Vicennati V, Pagotto U, Pasquali R. 2002. Obesity and the polycystic ovary syndrome. Int J Obes Relat Metab Disord 26:883–96. doi:10.1038/sj.ijo.0801994
Gill H, Tiwari P, Dabadghao P. 2013. Prevalence of polycystic ovary syndrome in young women from North India: A Community-based study [published correction appears in Indian]. J Endocrinol Metab 17(1):162. doi:10.4103/2230-8210.10410
Gowri BV, Chandravathi PL, Sindhu PS, Naidu KS. 2015.Correlation of skin changes with hormonal changes in polycystic ovarian syndrome: A cross sectional study clinical study. Indian journal of dermatology. 60(4):419. doi:10.4103/0019-5154.160505.
Hartz AJ, Barboriak PN, Wong A, Katayama KP, Rimm AA. 1979. The association of obesity with infertility and related menstrual abnormalities in women. Int J Obes 3(1):57–77.
Holte J, Gennarelli G, Wide L. 1994. The independent effects of polycystic ovary syndrome and obesity on serum concentrations of gonadotropins and sex steroids in premenopausal women. Clin Endocrinol (Oxf) 41:473–81.
Hsu MI. 2015. Clinical characteristics in Taiwanese women with polycystic ovary syndrome. Clin Exp Reprod Med 42(3):86–93. doi:10.5653/cerm.2015.42.3.86
Joseph N, Reddy AG, Joy D, Patel V, Santhosh P, Das S. et al. 2016. Study on the proportion and determinants of polycystic ovarian syndrome among health sciences students in South India.J Nat SciBiol Med 7(2):166–72. doi:10.4103/0976-9668.184704
Kahsar-Miller MD, Christa Nixon BS, Boots LR, Go RC, Azziz R. 2001. Prevalence of polycystic ovary syndrome (PCOS) in first-degree relatives of patients with PCOS. Fertil Sertil 75(1):53–8. doi: 10.1016/s0015-0282(00)01662-9
Kauffman RP, Baker VM, Dimarino P, Gimpel T, Castracane VD. 2002. Polycystic ovarian syndrome and insulin resistance in white and Mexican American women: A comparison of two distinct population. Am J Obstet Gynecol 187(5):1362–9. doi:10.4239/wjd.v2.i3.33
Kaur R, Kaur M, Suri V. 2020. Somatotype profile of obese and lean women with polycystic ovary syndrome: a population based cohort study. Anthropologie (Brno) 58(1):93–102. doi: https://doi.org/10.26720/anthro.20.02.07.1
Kiddy DS, Sharp PS, White DM, Scanlon MF, Mason HD, Bray CS. et al. 1990. Differences in clinical and endocrine features between obese and non obese subjects with polycystic ovary syndrome: an analysis of 263 consecutive cases. Clin Endocrinol 32(2):213–20.
Legro RS, Driscoll D, Strauss JF, Fox J, Dunaif A. 1998. Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome. PNAS 8, 95(25):14956–60.
Liou TH, Yang JH, Hsieh CH, Lee CY, Hsu CS, Hsu MI. 2009. Clinical and biochemical presentations of polycystic ovary syndrome among obese and nonobese women. Fertil Steril 92(6):1960–5. doi:10.1016/j.fertnstert.2008.09.003
Majumdar A, Singh TA. 2009. Comparison of clinical features and health manifestations in lean vs. obese Indian women with polycystic ovarian syndrome. J Hum Reprod Sci 2(1):12–17. doi: 10.4103/0974-1208.51336
Merkin SS, Azziz R, Seeman T, Calderon-Margalit R, Daviglus M, Kiefe C. et al. 2011 Socio-economic status and polycystic ovary syndrome. J Womens Health (Larchmt) 20(3): 413-9. doi: 10.1089/jwh.2010.2303
Moran LJ, Noakes M, Clifton PM, Tomlinson L, Norman RJ. 2003. Dietary Composition in Restoring Reproductive and Metabolic Physiology in Overweight Women with Polycystic Ovary Syndrome. J Clin Endocrinol Metabol 88(2):812–9. doi:10.1210/jc.2002-020815
Munro MG, Critchley HOD, Fraser IS. 2018. The two FIGO systems for normal and abnormal uterine bleeding symptoms and classification of causes of abnormal uterine bleeding in the reproductive years: 2018 revisions. Int J Gynecol Obstet 143:393–408. doi: 10.1002/ijgo.12666
Noorbala MT, Kefaie P. 2010. The Prevalence of Hirsutism in Adolescent Girls in Yazd, Central Iran. Iran Red Crescent Med J 2:111–117.
Pathak G, Nichter M. 2015. Polycystic ovary syndrome in globalizing India: an ecosocial perspective on an emerging lifestyle disease. Soc Sci 146:21–8. doi:10.1016/j.socscimed.2015.10.007
Ramezani TF, Simbar M, Tohidi M, Hosseinpanah F, Azizi F. 2011. The prevalence of polycystic ovary syndrome in a community sample of Iranian population: Iranian PCOS prevalence study. Reprod Biol Endocrinol 39:1–7. doi: 10.1186/1477-7827-9-39
Reid SP, Chia-Ning K, Pasch L, Shinkai K, Cedars M, Huddleston H. et al. 2017. Ovarian morphology is associated with insulin resistance in women with polycystic ovary syndrome: a cross sectional study. Fertility Research and Practice 3:1–7. doi:10.1186/s40738-017-0035-z
Reilly MW, Taylor AE, Crabtree NJ, Hughes BA, Capper F, Crowley RK. et al. 2014. Hyperandrogenism predicts metabolic phenotype in polycystic ovary syndrome: the utility of serum androstenedione. J Clin Endocrinol Metab 99(3):1027–36. doi: 10.1210/jc.2013-3399
Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 (2004) consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81(1):19–25. doi:10.1016/j.fertnstert.2003.10.004
Sharma, N.L., Mahajan, V.K., Jindal, R., Gupta, M., Lath, A. (2008).Hirsutism: Clinico-investigate profile of 50 Indian patients. Indian J Dermatol. 53(3), 111–114. Doi: 10.4103/0019-5154.42387
Tamimi W, Siddiqui I, Tamim H, Al Eisa N, Adham M. 2009. Effect of body mass index on clinical manifestations in patients with polycystic ovary syndrome. Int J Gynecol Obstet 107(1):54–7. doi: 10.1016/j.ijgo.2009.06.003
Tanner JM, Whitehouse RH, Takaishi M. 1966. Standards from birth to maturity for height, weight, height velocity and weight velocity in British children. Archieve Dis Child 41:454–613.
Voutilainen R, Jaaskelainen J. 2014. Premature adrenarche: Etiology, clinical findings, and consequences. J Steroid Biochem Mol Biol 145:226–36. doi: https://doi.org/10.1016/j.jsbmb.2014.06.004
Welt CK, Gudmundsson JA, Arason G, Adams J, Palsdottir H, Gudlaugsdottir G. et al. 2006.Characterizing discrete subsets of polycystic ovary syndrome as defined by the Rotterdam criteria: the impact of weight on phenotype and metabolic features. J Clin Endocrinol Metab 91(12):4842–8. doi: https://doi.org/10.1210/jc.2006-1327
WHO expert consultation. 2004. Appropriate body-mass index for Asian population and its implications for policy and intervention strategies. Lancet 363:157–63. doi: 10.1016/S0140-6736(03)15268-3
Wijeyaratne CN, Jayasinghe A, de Silva DG, Parkes AB, Lazarus JH, Premawardhana LD. 2005. Iodine prophylaxis, goitre and thyroid autoimmunity in Sri Lanka. Ceylon Med J 50(1):20–23. doi: 10.4038/cmj.v50i1.1585
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
How to Cite
